| COX-2 as a potential biomarker and therapeutic target in melanoma DV Tudor, I Bâldea, M Lupu, T Kacso, E Kutasi, A Hopârtean, R Stretea, ... Cancer biology & medicine 17 (1), 20, 2020 | 68 | 2020 |
| Influence of mitochondrial and systemic iron levels in heart failure pathology M Lupu, DV Tudor, GA Filip Heart Failure Reviews 24 (5), 647-659, 2019 | 14 | 2019 |
| Celecoxib as a valuable adjuvant in cutaneous melanoma treated with trametinib DV Tudor, I Bâldea, DE Olteanu, E Fischer-Fodor, V Piroska, M Lupu, ... International Journal of Molecular Sciences 22 (9), 4387, 2021 | 10 | 2021 |
| Iron chelation effects on lipid peroxidation, inflammation and ventricular performance in a rat model of isoproterenol induced acute myocardial stress M Lupu, DV Tudor, VA Toma, A Florea, A Lupsor, R Moldovan, B Stancu, ... JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 73 (3), 363-370, 2022 | 6 | 2022 |
| Iron chelation alleviates multiple pathophysiological pathways in a rat model of cardiac pressure overload M Lupu, CA Coada, DV Tudor, I Baldea, A Florea, VA Toma, A Lupsor, ... Free Radical Biology and Medicine 200, 1-10, 2023 | 2 | 2023 |
| Iron metabolism and cardiovascular disease: Basic to translational purviews and therapeutical approach M Lupu, D Tudor, A Filip Revista Portuguesa de Cardiologia 41 (12), 1037-1046, 2022 | 2 | 2022 |
